Fig. 3From: Increasing power in the analysis of responder endpoints in rheumatology: a software tutorialAnalysis of the SRI + OCS endpoint in the phase II MUSE trial where the tables show the probability of response in each method, the treatment effects and 95% CIs using the latent variable method and the treatment effects and 95% CIs using the standard binary methodBack to article page